Literature DB >> 24584618

Prognostic value of serum von Willebrand factor, but not soluble ICAM and VCAM, for mortality and cardiovascular events is independent of residual renal function in peritoneal dialysis patients.

Jie Dong1, Yan-Jun Li1, Zhi-Kai Yang1, Rong Xu1.   

Abstract

OBJECTIVE: We explored associations between markers of endothelial dysfunction and outcome events, and whether those associations were independent of residual renal function (RRF) in patients on peritoneal dialysis.
METHODS: The study enrolled 261 incident patients and 68 healthy control subjects who were followed till death, censoring, or study end. Demographics, biochemistry, markers of inflammation (C-reactive protein) and endothelial dysfunction [soluble intercellular adhesion molecule 1 (sICAM), soluble vascular adhesion molecule 1 (sVCAM), and von Willebrand factor (vWf)] were examined at baseline. Outcome events included all-cause death and fatal and nonfatal cardiovascular (CV) events.
RESULTS: Mean levels of vWf, sICAM, and sVCAM were significantly higher in patients than in healthy control subjects. Levels of sICAM and sVCAM, but not vWf, were significantly correlated with RRF. Levels of sICAM and vWf both predicted all-cause mortality and fatal and nonfatal CV events after adjustment for recognizable CV risk factors. The association between sICAM and outcome events disappeared after further adjustment for RRF. However, RRF did not change the predictive role of vWf for outcome events. Compared with the lowest vWf quartile (6.6% - 73.9%), the highest vWf quartile (240.9% - 1161%) predicted the highest risk for fatal and nonfatal CV events (adjusted hazard ratio: 2.05; 95% confidence interval: 1.15 to 3.64; p = 0.014). We observed no associations between sVCAM and RRF, or sVCAM and any outcome event.
CONCLUSIONS: The prognostic value of vWf, but not sICAM, is independent of RRF in predicting mortality and CV events.
Copyright © 2014 International Society for Peritoneal Dialysis.

Entities:  

Keywords:  Cardiovascular mortality; sICAM; sVCAM; soluble intercellular adhesion molecule 1; soluble vascular adhesion molecule 1; vWf; von Willebrand factor

Mesh:

Substances:

Year:  2014        PMID: 24584618      PMCID: PMC4269496          DOI: 10.3747/pdi.2012.00004

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  32 in total

1.  von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects: the Hoorn Study.

Authors:  A Jager; V W van Hinsbergh; P J Kostense; J J Emeis; J S Yudkin; G Nijpels; J M Dekker; R J Heine; L M Bouter; C D Stehouwer
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

2.  Plasma concentration of von Willebrand factor predicts mortality in patients on chronic renal replacement therapy.

Authors:  Nathalie C Péquériaux; Rob Fijnheer; Eugenie F Gemen; Arjan D Barendrecht; Friedo W Dekker; Raymond T Krediet; Jaap J Beutler; Elisabeth W Boeschoten; Mark Roest
Journal:  Nephrol Dial Transplant       Date:  2011-12-20       Impact factor: 5.992

3.  Carotid atherosclerosis is associated with inflammation and endothelial cell adhesion molecules in chronic haemodialysis patients.

Authors:  Aikaterini Papagianni; Michalis Kalovoulos; Dimitrios Kirmizis; Andreas Vainas; Anna-Maria Belechri; Efstathios Alexopoulos; Dimitrios Memmos
Journal:  Nephrol Dial Transplant       Date:  2003-01       Impact factor: 5.992

4.  von Willebrand factor and coronary heart disease: prospective study and meta-analysis.

Authors:  P H Whincup; J Danesh; M Walker; L Lennon; A Thomson; P Appleby; A Rumley; G D O Lowe
Journal:  Eur Heart J       Date:  2002-11       Impact factor: 29.983

5.  Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity.

Authors:  Frank Stam; Coen van Guldener; Casper G Schalkwijk; Piet M ter Wee; Ab J M Donker; Coen D A Stehouwer
Journal:  Nephrol Dial Transplant       Date:  2003-05       Impact factor: 5.992

6.  Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

Authors:  C Zoccali; S Bode-Böger; F Mallamaci; F Benedetto; G Tripepi; L Malatino; A Cataliotti; I Bellanuova; I Fermo; J Frölich; R Böger
Journal:  Lancet       Date:  2001 Dec 22-29       Impact factor: 79.321

7.  Circulating levels of ICAM-1, VCAM-1, and MCP-1 are increased in haemodialysis patients: association with inflammation, dyslipidaemia, and vascular events.

Authors:  Aikaterini Papayianni; Efstathios Alexopoulos; Panagiotis Giamalis; Lazaros Gionanlis; Anna-Maria Belechri; Paraschos Koukoudis; Dimitrios Memmos
Journal:  Nephrol Dial Transplant       Date:  2002-03       Impact factor: 5.992

8.  Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patients: association with malnutrition, inflammation, and cardiovascular disease.

Authors:  P Stenvinkel; B Lindholm; M Heimbürger; O Heimbürger
Journal:  Nephrol Dial Transplant       Date:  2000-10       Impact factor: 5.992

Review 9.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Hypertension       Date:  2003-11       Impact factor: 10.190

10.  An experimental model to study the in vivo survival of von Willebrand factor. Basic aspects and application to the R1205H mutation.

Authors:  Peter J Lenting; Erik Westein; Virginie Terraube; Anne-Sophie Ribba; Eric G Huizinga; Dominique Meyer; Philip G de Groot; Cécile V Denis
Journal:  J Biol Chem       Date:  2003-11-12       Impact factor: 5.157

View more
  5 in total

1.  Indoxyl sulfate - the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease.

Authors:  Tomasz W Kamiński; Krystyna Pawlak; Małgorzata Karbowska; Michał Myśliwiec; Dariusz Pawlak
Journal:  BMC Nephrol       Date:  2017-01-25       Impact factor: 2.388

2.  Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.

Authors:  April C E van Gennip; Natascha J H Broers; Karlien J Ter Meulen; Bernard Canaud; Maarten H L Christiaans; Tom Cornelis; Mariëlle A C J Gelens; Marc M H Hermans; Constantijn J A M Konings; Jeroen B van der Net; Frank M van der Sande; Casper G Schalkwijk; Frank Stifft; Joris J J M Wirtz; Jeroen P Kooman; Remy J H Martens
Journal:  PLoS One       Date:  2019-09-13       Impact factor: 3.240

3.  Relationship between the serum levels of Vitamin D and inflammatory markers in ESRD patients.

Authors:  Abbas Etminan; Seyed Mostafa Seyed Askari; Ahmad Naghibzade Tahami; Seyed Adel Mahdi; Mina Behzadi; Mohammad Shabani
Journal:  Acta Biomed       Date:  2020-11-10

4.  Secretory activity of the coronary artery endothelial cells in conditions of the peritoneal dialysis.

Authors:  Monika Misian; Ewa Baum; Andrzej Bręborowicz
Journal:  Ren Fail       Date:  2022-12       Impact factor: 2.606

5.  Effect of Acute Myocardial Infarction on a Disintegrin and Metalloprotease with Thrombospondin Motif 13 and Von Willebrand Factor and Their Relationship with Markers of Inflammation.

Authors:  Abeer A Al-Masri; Syed Shahid Habib; Ahmad Hersi; Hana Al Zamil
Journal:  Int J Vasc Med       Date:  2020-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.